# Patheon to acquire API manufacturing facility from Roche in South Carolina

Patheon signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina from Roche Holdings for an immaterial sum plus inventory and spare parts. The deal includes a multi-year supply arrangement with Roche.

- Type: Acquisition
- Announced: 2016-11-28
- Where: Florence, South Carolina, United States
- Status: announced
- Products: active pharmaceutical ingredients (API), highly potent compounds
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Patheon N.V.](https://endata.com/companies/16414.md) (acquirer)
- [Roche Holdings Inc](https://endata.com/companies/16415.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20161128005434/en/ADDING-MULTIMEDIA-Patheon-Acquire-State-of-the-Art-Manufacturing-Site), 2016-11-28: "Patheon N.V. announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.